GLP 1 News and Research

RSS
Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition

Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition

New therapy shows greater weight loss in mice by targeting brain's appetite center

New therapy shows greater weight loss in mice by targeting brain's appetite center

Anti-obesity medications slash heart disease risk in obese patients, study finds

Anti-obesity medications slash heart disease risk in obese patients, study finds

Technology alone insufficient for meaningful weight loss in obesity, study shows

Technology alone insufficient for meaningful weight loss in obesity, study shows

Sustainable weight loss with personalized semaglutide dosing

Sustainable weight loss with personalized semaglutide dosing

Aerobic exercise proves most effective for combating obesity-related inflammation

Aerobic exercise proves most effective for combating obesity-related inflammation

Enhanced weight loss outcomes with GLP-1 analogues and bupropion/naltrexone combination

Enhanced weight loss outcomes with GLP-1 analogues and bupropion/naltrexone combination

Innovative endoscopic treatment targets hunger hormone for weight loss

Innovative endoscopic treatment targets hunger hormone for weight loss

TIME reveals new list recognizing the 100 most influential individuals in health

TIME reveals new list recognizing the 100 most influential individuals in health

Metabolic health determines effectiveness of influenza vaccination

Metabolic health determines effectiveness of influenza vaccination

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Popular diabetes drugs not linked to thyroid cancer risk, study finds

Popular diabetes drugs not linked to thyroid cancer risk, study finds

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

AI-based analysis uncovers two plant extracts with potential as GLP-1 agonist weight loss pills

AI-based analysis uncovers two plant extracts with potential as GLP-1 agonist weight loss pills

New research sheds light on how GLP-1 obesity drugs may change food cravings

New research sheds light on how GLP-1 obesity drugs may change food cravings

Diabetes drug dulaglutide may reduce symptoms of depression

Diabetes drug dulaglutide may reduce symptoms of depression

Study reveals mechanisms behind antidepressant effects of diabetes drug

Study reveals mechanisms behind antidepressant effects of diabetes drug

New hope for binge eating and bulimia: GLP-1 drugs could be the key

New hope for binge eating and bulimia: GLP-1 drugs could be the key

Gut bacteria diversity linked to body weight, athletes show healthier profiles

Gut bacteria diversity linked to body weight, athletes show healthier profiles

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.